- Parties: The plaintiffs were Janssen Inc. and Actelion Pharmaceuticals Ltd. The defendant was Pharmascience Inc.

- Subject Matter: This is a Federal Court action under the Patented Medicines (Notice of Compliance) Regulations between Janssen Inc. et al. (plaintiffs) and Pharmascience Inc. (defendant), commenced by Statement of Claim filed October 4, 2024 and continued as a specially managed proceeding. The docket reflects extensive interlocutory activity, including motions for particulars, to compel further answers on discovery, and for leave to amend pleadings, together with protective and sealing orders. The case is ongoing.

- Date: The hearing was set on June 24, 2026.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.